Electrochemistry is a hot field. Argonne is elevating its role in the University of Illinois Chicago’s Next Generation Electrochemistry workshop, which attracts the next generation of scientists to study the quickly expanding field.
Arexvy has been shown to prevent severe illness brought on by respiratory syncytial virus, which affects millions every year. The U.S. Food and Drug Administration has approved Arexvy for people 60 years old or older.
Climate change is bringing flooding, heat islands and extreme weather to Chicago. An Argonne-led project from the U.S. Department of Energy’s Urban Integrated Field Laboratory will help neighborhoods understand and adapt to the city’s changing climate.